A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer

Clinical prognostic model for older patients with advanced non-small cell lung cancer

AK Ganti;X Wang;T Stinchcombe;Y Wang;J Bradley;HJ Cohen;K Kelly;R Paulus;SS Ramalingam;EE Vokes;H Pang Journal of Geriatric Oncology Feb 20. pii: S1879-4068(18)30197-8. doi: 10.1016/j.jgo.2019.02.007. [Epub ahead of print]

PMid: PMID30797707

Patient demographics in HOG LUN 01-24 versus SWOG 9504: apples versus oranges [PMID17922970]

LE Gaspar Clinical Lung Cancer 8(9):478-482

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group study (S9504)

DR Gandara;K Chansky;KS Albain;LE Gaspar;PN Lara Jr;K Kelly;K Crowley;RB Livingston Clinical Lung Cancer 8(2):116-121

Long term survival in stage IIIb non-small cell lung cancer (NSCLC) treated with consolidation docetaxel following concurrent chemoradiotherapy (SWOG S9504)

DR Gandara;K Chansky;LE Gaspar;KS Albain;PN Lara;J Crowley Proc of the ASCO, JCO 23(16S):635s (#7059)

Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.

LE Gaspar;K Chansky;KS Albain;E Vallieres;V Rusch;JJ Crowley;RB Livingston;DR Gandara Journal of Clinical Oncology 23(13):2955-2961

Southwest Oncology Group: Two decades of experience in non-small cell lung cancer

AT Turrisi;J Crowley;K Albain;L Gaspar;D Gandara Seminars in Oncology 32(2Suppl3):S119-S121

PMid: PMID16015548

Therapeutic strategies for combined-modality therapy of locally advanced non-small cell lung cancer: rationale for consolidation docetaxel therapy

DR Gandara;E Vallieres;LE Gaspar;K Kelly;KS Albain;RS Herbst Jr;PN Lara Jr;P Mack;PH Gumerlock;JJ Crowley Clinical Lung Cancer 7 Suppl 3:S93-97

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group study S9504

DR Gandara;K Chansky;KS Albain;BR Leigh;LE Gaspar;PN Lara;H Burris;P Gumerlock;JP Kuebler;JD Bearden;J Crowley;R Livingston Journal of Clinical Oncology 21(10):2004-2010

Consolidation docetaxel following concurrent chemoradiotherapy in pathologic stage IIIb non-small cell lung cancer (NSCLC) (SWOG 9504): patterns of failure and updated survival

LE Gaspar;DR Gandara;K Chansky;KS Albain;PN Lara Jr;JJ Crowley;RB Livingston Proc of the American Society of Clinical Oncology 20:315a(#1255)

Prolonged survival in pathologic stage IIIb non-small cell lung cancer (NSCLC) with concurrent chemoradiotherapy followed by consolidation docetaxel: a phase II study (S9504) of the Southwest Oncology Group (SWOG).

DR Gandara;LC Lovato; KS Albain;B Leigh;PN Lara;JJ Crowley;K Stelzer;RB Livingston Proc of the American Society of Clinical Oncology 19:490a(#1916)

Pathologic stage IIIb non-small cell lung cancer (NSCLC): prolonged survival with consolidation docetaxel following concurrent chemoradiotherapy (SWOG 9504).

DR Gandara;LC Lovato;KS Albain;B Leigh;PN Lara;JJ Crowley;RB Livingston Lung Cancer 29(Suppl.2):92(#302)